Known targets — ChEMBL curated mechanism
SLC6A2SLC6A3SSTR1SSTR2SSTR3SSTR5
The experimentally established mechanism targets of Aspartic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.39 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.37 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.37 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.37 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.37 |
| ▸ | GRM8 | O00222 | 1/20 | 0.37 |
| ▸ | GRM6 | O15303 | 1/20 | 0.37 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.37 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.37 |
| ▸ | GSR | P00390 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | GRM5 | P41594 | 1/20 | 0.37 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.37 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.37 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.37 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aspartic Acid SCHEMBL10601207 | 0.97 | SLC22A6 (0.38) | SLC22A6GABRR1LMNATDP1GRIK1 | |
| Aspartic Acid SCHEMBL17747944 | 0.97 | SLC22A6 (0.38) | SLC22A6GABRR1LMNATDP1GRIK1 | |
| Aspartic Acid SCHEMBL4019503 | 0.97 | SLC22A6 (0.38) | SLC22A6GABRR1LMNATDP1GRIK1 | |
| Aspartic Acid SCHEMBL3976768 | 0.97 | SLC22A6 (0.38) | SLC22A6GABRR1LMNATDP1GRIK1 | |
| Aspartic Acid SCHEMBL1987594 | 0.97 | SLC22A6 (0.41) | SLC22A6GABRR1LMNATDP1GRIK1 | |
| Aspartic Acid SCHEMBL50775 | 0.95 | SLC22A6 (0.39) | SLC22A6GABRR1LMNATDP1GRIK1 | |
| Aspartic Acid SCHEMBL16431399 | 0.95 | SLC22A6 (0.39) | SLC22A6GABRR1LMNATDP1GRIK1 | |
| Aspartic Acid SCHEMBL5247248 | 0.95 | SLC22A6 (0.39) | SLC22A6GABRR1LMNATDP1GRIK1 | |
| Aspartic Acid SCHEMBL14343482 | 0.95 | SLC22A6 (0.39) | SLC22A6GABRR1LMNATDP1GRIK1 | |
| Aspartic Acid SCHEMBL518279 | 0.95 | SLC22A6 (0.39) | SLC22A6GABRR1LMNATDP1GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1643 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122056387-A | Composition for promoting joint health and preparation method and application thereof | 吉林衡美宇创健康科技有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122056386-A | Moisture absorption resistant slow release microcapsule powder and preparation method and application thereof | 大连医诺生物股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122030612-A | Shear-resistant slow-release microcapsule powder and preparation method and application thereof | 大连医诺生物股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| US-12582149-B1 | Functional additive for hot beverages and foods | MILJKOVIC IGOR (US) | 2026-03-24 | — | — | US | claimed |
| US-20260081133-A1 | ZINC ELECTRODE FOR ALKALINE NICKEL-ZINC BATTERY AND PREPARATION METHOD THEREFOR | DONGGUAN CHAO BA BATTERIES CO LTD SHENZHEN INNOVATION CENTER (CN) | 2026-03-19 | — | — | US | claimed |
| EP-4627938-A1 | COMPOSITION FOR RESISTING ENTERITIS AND/OR PROTECTING INTEGRITY OF INTESTINAL BARRIER, AND USE THEREOF | Inner Mongolia Yili Industrial Group Co. Ltd. (CN) | 2025-10-08 | — | — | EP | claimed |
| EP-4298923-B1 | METHOD FOR PREVENTING CAKING OF XYLITOL AND CALCIUM ASPARTATE MIXTURE | ZHEJIANG HUAKANG PHARMACEUTICAL CO LTD (CN) | 2025-06-18 | — | — | EP | claimed |
| CN-119970605-A | Whitening toothpaste capable of preventing caries and inhibiting dental plaque and preparation method thereof | 广州虹云峰科技有限责任公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119924527-A | Composition for promoting bone health and bone formation, application and product thereof | 合生元(长沙)营养食品有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119769737-A | Gamma-aminobutyric acid product and preparation method thereof | 江西维莱营健高科有限公司 | 2025-04-08 | — | — | CN | claimed |
| WO-1999026491-A1 | FORTIFIED CONFECTIONERY DELIVERY SYSTEMS AND METHODS OF PREPARATION THEREOF | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-06-03 | — | — | WO | claimed |
| EP-0909992-A1 | Water-soluble photoresist composition | Fuji Chemicals Industrial Co., Ltd. (JP) | 1999-04-21 | — | — | EP | claimed |
| EP-0770057-A1 | METHOD FOR PRODUCING CALCIUM SALTS OF [S,S]-ETHYLENEDIAMINE-N,N'-DISUCCINIC ACID | ALBEMARLE CORPORATION (US) | 1997-05-02 | — | — | EP | claimed |
| US-5550285-A | Method for producing calcium salts of [S,S]-ethylenediamine-N,N'-disuccinic acid | ALBEMARLE CORPORATION | 1996-08-27 | — | — | US | claimed |
| WO-1996001804-A1 | METHOD FOR PRODUCING CALCIUM SALTS OF [S,S]-ETHYLENEDIAMINE-N,N'-DISUCCINIC ACID | ALBEMARLE CORPORATION (US) | 1996-01-25 | — | — | WO | claimed |
| US-4738856-A | Beverage and method for making a beverage for the nutritional supplementation of calcium in humans | NUTRITION TECHNOLOGIES, INC. (US) | 1988-04-19 | — | — | US | claimed |
| EP-0246177-A2 | A beverage and method for making a beverage for the nutritional supplementation of calcium in humans | Clark, George H. (US) | 1987-11-19 | — | — | EP | claimed |
| US-4479840-A | SYNTHETIC RESIN EMULSION AND GELLING AGENT; ORGANIC AND INORGANIC SALTS | SUNSTAR GIKEN KABUSHIKI (JP) | 1984-10-30 | — | — | US | claimed |
| US-4386992-A | Two-part adhesive and bonding method employing same | SUNSTAR CHEMICAL IND. CO., LTD. (JP) | 1983-06-07 | — | — | US | claimed |
| US-4288619-A | AS CALCIUM SALTS, ION EXCHANGE RESIN | ROQUETTE FRERES (FR) | 1981-09-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260081133-A1 | ZINC ELECTRODE FOR ALKALINE NICKEL-ZINC BATTERY AND PREPARATION METHOD THEREFOR | SLC39A11, SLC30A7, SLC39A7 | SLC22A6 1508/4885GABRR1 535/4885LMNA 2911/4885 |
| US-12582149-B1 | Functional additive for hot beverages and foods | SOD1, KCNN1, KCNN3 | SLC22A6 1697/4885GABRR1 1403/4885LMNA 4037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.